BOCA RATON, Fla., July 10, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), and CellMark Medical, a global supply chain service company, today announced a new partnership to support and accelerate international growth and encourage worldwide […]
Blog
People Magazine – 42-Year-Old Woman Has Survived 86 Skin Cancer Surgeries
Lisa Pace has had 86 skin cancer surgeries and she’s only 42 years old. She was in her 20s when she discovered she had skin cancer after years of using tanning beds. In her interview with People Magazine, she discusses the importance of sun-protection and the dangers of tanning beds. She adds: “I want people to realize that it can […]
Skin Cancer and SRT – Jeff Goldstein Interview
All transplant patients have a greater chance of developing skin cancer compared to the general population. In fact, research shows that transplant recipients have up to a 100 times higher risk for developing skin cancer compared to the general population. Transplant patients tend to develop a skin cancer called squamous cell carcinoma (SCC) although many […]
Utilizing the SRT Keloid Treatment To Help Change Lives
The SRT Keloid Treatment helps to change lives. To show you just how effective SRT can be for keloids, we wanted to share the story of a patient who was successfully treated with the SRT-100. Tony Perkins, a teacher from St. Louis, came to Dr. Michael Jones after seeing a number of plastic surgeons for […]
Sensus Healthcare to Join Russell Microcap® Index
BOCA RATON, Fla., June 25, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that it is set to join the Russell Microcap® Index at the conclusion of the Russell U.S. Indexes annual reconstitution, effective before […]
WFN1 News – Dermatologist Dr. Ellen Turner on CEO Money
In this week’s CEO Money segment Michael Yorba sits down with Dallas dermatologist, Dr. Ellen Turner to learn about skin cancer, and why her practice is using Superficial Radio Therapy (SRT) — a new, non-surgical skin cancer treatment option that has a remarkable cure rate. Read the full article and listen to the interview here.
Sensus Healthcare to Participate in Panel Discussion at the Cantor Fitzgerald Dermatology & Aesthetics Summit
BOCA RATON, Fla., June 12, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare, will participate in a panel discussion, titled “New Treatments for Rare/Orphan […]
City & Shore – Alternative Treatment to Skin Cancer Surgery
City & Shore Magazine recently wrote an article regarding the alternative treatment options to skin cancer surgery. Dr. Jason Green, DO and SRT was featured in the article. Check out the full article here.
Practical Dermatology – Solving the Keloid Conundrum
Achieving complete keloid scar removal is extremely difficult. The SRT-100 is the only FDA cleared treatment after keloid removal option on the market. Recently the machine was featured in an article on Practical Dermatology’s website. Read the full article here. Read more blogs and news here.
The Aesthetic Show
Join Sensus Healthcare at The Aesthetic Show in Las Vegas, NV July 5th – 8th, 2018. For tickets and more information click here.
Fox News – The Best Sunscreens, According to a Top Dermatologist
Sunscreen is meant for the purpose of protecting your skin from the harmful UV rays that cause can sunburn and skin cancer. What you may not realize is that no two sunscreens are entirely alike. Lindsey Carlton from Fox News and dermatologist Dr. Whitney Bowe break down the best sunscreens currently on the market and […]
AuntMinnie.com – Sensus Names New VP of Clinical Development
May 21, 2018 — Superficial radiation therapy provider Sensus Healthcare has appointed Isabelle Raymond, PhD, as vice president (VP) of clinical development. Read the full article here.
Dr. Schewe Discusses the SRT-100 and Skin Cancer on Colorado News 9
Dr. Schewe from Alliance Cancer Care Colorado at Red Rocks discusses the revolutionary ways the SRT-100 treats skin cancer. Click the link or watch the video below to learn more.
ASMS – American Society for Mohs Surgery Annual Meeting: Focus on Skin Cancer
Join Sensus Healthcare at the 2018 ASMS – American Society for Mohs Surgery Annual Meeting: Focus on Skin Cancer in Orlando, FL May 24th-27th, 2018. For tickets and more information click here. Join Sensus Healthcare at the 2018 ASMS – American Society for Mohs Surgery Annual Meeting. Click here
Medical Device News Magazine – Dr. Isabelle Raymond Appointed Vice President of Clinical Development of Sensus Healthcare
May 8, 2018 -Dr. Isabelle Raymond Appointed Vice President of Clinical Development of Sensus Healthcare. Dr. Raymond, who will report to Joe Sardano, Sensus CEO, brings 14 years of medical device and pharmaceutical industry experience to the Company. Read the full article here.
AuntMinnie.com – Sensus Appoints New Sales VP for Oncology
May 8, 2018 — Superficial radiation therapy provider Sensus Healthcare has appointed Rita Gable as its new vice president of sales for oncology, effective immediately. Read the full article here.
Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development
New Executive Leader Brings Extensive Clinical Research, Medical Marketing and Product Launch Experience to the Company BOCA RATON, Fla., May 8, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced the appointment of Dr. Isabelle Raymond, […]
Sensus Healthcare Reports First Quarter Financial Results Featuring 37% Revenue Growth
Ships 21 systems with SRT-100 Vision™ systems sales continuing to rise Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 3, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]
DermWire – Sensus Appoints Rita Gable as VP of Sales, Oncology
May 3, 2018 –Sensus Healthcare, Inc. has appointed Rita Gable as Vice President of Sales – Oncology. Ms. Gable, who will report to Joe Sardano, Sensus CEO, has 15 years of sales experience, specializing in the oncology market. Read the full article here.
Sensus Healthcare Appoints Rita Gable as Vice President of Sales – Oncology
New Addition to Senior Leadership Team Brings 15 Years of Marketing Experience to Supercharge Sensus’ Domestic Oncology Efforts BOCA RATON, Fla., May 1, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today the appointment of […]